The review article titled"Current insights and future directions in Peyronie's disease management: A narrative review", was ...

The global interferons market is on a steady growth trajectory, with its valuation projected to surge from USD 9.4 billion in 2022 to USD 13.8 billion by 2032. According to a recent report by Future ...

A Phase 2 clinical trial finds that ALT flares are common in hepatitis D patients treated with pegylated interferon-alpha, ...

Interferon-alfa (Intron A) works on your immune system. It targets quickly dividing red blood cells to slow their production. A long-acting version, called peginterferon alfa (Pegasys), has fewer ...

Duke University blood cancer specialist Lindsay Rein, MD, has developed a rare expertise in myeloproliferative neoplasms ...